Search

Author/Creator Logan, Brent R

2. Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial. Issue 9 (September 2022)

Authors:
DeZern, Amy E; Eapen, Mary; Wu, Juan; Talano, Julie-An; Solh, Melhem; Dávila Saldaña, Blachy J; Karanes, Chatchada; Horwitz, Mitchell E; Mallhi, Kanwaldeep; Arai, Sally; Farhadfar, Nosha; Hexner, Elizabeth; Westervelt, Peter; Antin, Joseph H; Deeg, H Joachim; Leifer, Eric; Brodsky, Robert A; Loga...
Journal:
Lancet
Issue:
Volume 9:Issue 9(2022)
Page Start:
e660
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?. (9th September 2021)

Authors:
Wingard, John R; Alexander, Barbara D; Baden, Lindsey R; Chen, Min; Sugrue, Michele W; Leather, Helen L; Caliendo, Angela M; Clancy, Cornelius J; Denning, David W; Marty, Francisco M; Nguyen, M Hong; Wheat, L Joseph; Logan, Brent R; Horowitz, Mary M; Marr, Kieren A
Journal:
Open forum infectious diseases
Issue:
Volume 8:Number 10(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Molecular Correlates of Socioeconomic Status and Clinical Outcomes Following Hematopoietic Cell Transplantation for Leukemia. Issue 4 (12th September 2019)

Authors:
Knight, Jennifer M; Rizzo, J Douglas; Wang, Tao; He, Naya; Logan, Brent R; Spellman, Stephen R; Lee, Stephanie J; Verneris, Michael R; Arevalo, Jesusa M G; Cole, Steve W
Journal:
JNCI cancer spectrum
Issue:
Volume 3:Issue 4(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203). Issue 3 (March 2019)

Authors:
Bolaños-Meade, Javier; Reshef, Ran; Fraser, Raphael; Fei, Mingwei; Abhyankar, Sunil; Al-Kadhimi, Zaid; Alousi, Amin M; Antin, Joseph H; Arai, Sally; Bickett, Kate; Chen, Yi-Bin; Damon, Lloyd E; Efebera, Yvonne A; Geller, Nancy L; Giralt, Sergio A; Hari, Parameswaran; Holtan, Shernan G; Horowitz, ...
Journal:
Lancet
Issue:
Volume 6:Issue 3(2019)
Page Start:
e132
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗